Wake Up Wall Street (SPY) (QQQ): Joe Manchin, Omicron play equity grinches
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFERHere is what you need to know on Friday, December 17:
Equity markets retreated on Thursday as renewed fears over Omicron hit sentiment and Build Back Better looks unlikely to pass this year if at all. Infrastructure and green stocks were disproportionally knocked down a peg, and Tesla (TSLA) nearly reached our $910 target. President Biden and Senator Manchin are reportedly still miles away from reaching an agreement on the plan. This will hit stocks further in the new year if not sorted soon.
The Nasdaq was the big loser, index wise, on Thursday, as rate hike probabilities fed through to institutional investor positioning. Yield sensitive, unprofitable names will likely struggle, but so-called new defensives also struggled. The poster child for this new breed of cash-rich, defensive stocks, Apple (AAPL) fell 4% on Thursday.
The dollar, meanwhile, has reset and is stronger this morning at 1.1310 versus the euro. Bitcoin is $47,100, and oil is at $71.19, despite Goldman forecasting record demand for 2022 and 2023.
See Forex Today.
European markets are lower: Eurostoxx -0.85, FTSE +0.2% and Dax -15.
US futures are lower: S&P -0.6%, Dow -0.45 and Nasdaq -1%.
Wall Street (SPY) (QQQ) news
Record high for UK covid cases on Thursday.
Rivian (RIVN): Q3 earnings and production shortfall see stock fall 9%.
Tesla (TSLA): Elon sells more stock.
Apple (AAPL) slides 4% on Thursday.
FedEx (FDX) up 5% on reinstating 2022 forecasts.
Darden Restaurants (DRI) earnings beat on the top and bottom lines. CEO to retire in May.
Freshpet (FRPT) down 11% on lower guidance.
Johnson & Johnson (JNJ), Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX): US FDA recommends booster shots use only Moderna or Pfizer. JNJ down 2% premarket.
Novavax (NVAX): WHO issues emergency use listing.
US Steel (X) issues lower guidance than forecast, falls 4%.
Affirm (AFRM) down 2% as US launches probe into Buy Now Pay Later credit.
Cerner (CERN) up 18% on WSJ article that Oracle (ORCL) is in talks to buy it.
Upgrades and downgrades
Source: Benzinga Pro
Economic releases
Like this article? Help us with some feedback by answering this survey:
Here is what you need to know on Friday, December 17:
Equity markets retreated on Thursday as renewed fears over Omicron hit sentiment and Build Back Better looks unlikely to pass this year if at all. Infrastructure and green stocks were disproportionally knocked down a peg, and Tesla (TSLA) nearly reached our $910 target. President Biden and Senator Manchin are reportedly still miles away from reaching an agreement on the plan. This will hit stocks further in the new year if not sorted soon.
The Nasdaq was the big loser, index wise, on Thursday, as rate hike probabilities fed through to institutional investor positioning. Yield sensitive, unprofitable names will likely struggle, but so-called new defensives also struggled. The poster child for this new breed of cash-rich, defensive stocks, Apple (AAPL) fell 4% on Thursday.
The dollar, meanwhile, has reset and is stronger this morning at 1.1310 versus the euro. Bitcoin is $47,100, and oil is at $71.19, despite Goldman forecasting record demand for 2022 and 2023.
See Forex Today.
European markets are lower: Eurostoxx -0.85, FTSE +0.2% and Dax -15.
US futures are lower: S&P -0.6%, Dow -0.45 and Nasdaq -1%.
Wall Street (SPY) (QQQ) news
Record high for UK covid cases on Thursday.
Rivian (RIVN): Q3 earnings and production shortfall see stock fall 9%.
Tesla (TSLA): Elon sells more stock.
Apple (AAPL) slides 4% on Thursday.
FedEx (FDX) up 5% on reinstating 2022 forecasts.
Darden Restaurants (DRI) earnings beat on the top and bottom lines. CEO to retire in May.
Freshpet (FRPT) down 11% on lower guidance.
Johnson & Johnson (JNJ), Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX): US FDA recommends booster shots use only Moderna or Pfizer. JNJ down 2% premarket.
Novavax (NVAX): WHO issues emergency use listing.
US Steel (X) issues lower guidance than forecast, falls 4%.
Affirm (AFRM) down 2% as US launches probe into Buy Now Pay Later credit.
Cerner (CERN) up 18% on WSJ article that Oracle (ORCL) is in talks to buy it.
Upgrades and downgrades
Source: Benzinga Pro
Economic releases
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.